The Inflation Reduction Act could lower out-of-pocket costs by around $7.4 billion in 2025 for more than a third of all Americans enrolled in Medicare Part D, according to a ...

GE Health­Care is criss­cross­ing the coun­try in a big pur­ple bus to in­tro­duce hos­pi­tal teams to some of its newest health­care tech­nolo­gies.

New data on an injectable form of Eisai's Alzheimer's drug, Leqembi, showed that it was more effective than an intravenous version at clearing amyloid but also came with a higher ...

Galderma’s annual push, and funding donation, for breast cancer awareness during October this year is focused on the personal stories of survivors who’ve used its aesthetics products to feel ...

Novo Nordisk spelled out how it will try to catch up with the extraordinary demand for its GLP-1 drugs, underscoring its rationale for its in-house API production and strategic fill ...

Eli Lilly will pay up to $1.925 billion in cash for weight loss drugmaker Versanis, marking the Big Pharma’s fourth acquisition this summer after deals for DICE Therapeutics, Sigilon and ...

Vertex sued the federal government on Monday in an effort to expand its fertility support program to certain patients taking its new gene therapy for sickle cell disease and transfusion ...

French biotech Smart Immune has raised more than half of its roughly €50 million ($54 million) target in an ongoing Series A round, with an eye to completing Phase I ...

Gene therapy startup enGene became a public biotech on Wednesday after completing its combination with Forbion European Acquisition, a blank check company formed in 2021. The Montreal and ...

CVS Health is shut­ting down the clin­i­cal tri­als busi­ness that it launched just two years ago, part of an ef­fort to fo­cus on its core … ...

The FDA is hoping its latest solution will stave off the continued shortage of cisplatin, a key drug used in treating several types of cancer. Beginning ...

Endpoints Health Tech newsletter wins SABEW award for business journalism, recognized for coverage of healthcare industry issues including weight loss drugs and value-based care.